A detailed history of Gk Wealth Management LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Gk Wealth Management LLC holds 18,801 shares of ARQT stock, worth $267,350. This represents 0.24% of its overall portfolio holdings.

Number of Shares
18,801
Previous 14,667 28.19%
Holding current value
$267,350
Previous $229 Million 14.91%
% of portfolio
0.24%
Previous 0.26%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 07, 2025

BUY
$12.59 - $16.6 $52,047 - $68,624
4,134 Added 28.19%
18,801 $264 Million
Q1 2025

Jul 07, 2025

BUY
$11.4 - $17.29 $48,051 - $72,877
4,215 Added 40.33%
14,667 $229 Million
Q1 2025

May 28, 2025

BUY
$11.4 - $17.29 $119,152 - $180,715
10,452 New
10,452 $163 Million

Others Institutions Holding ARQT

About Arcutis Biotherapeutics, Inc.


  • Ticker ARQT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,187,500
  • Market Cap $856M
  • Description
  • Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...
More about ARQT
Track This Portfolio

Track Gk Wealth Management LLC Portfolio

Follow Gk Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gk Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gk Wealth Management LLC with notifications on news.